Patients (n) | Proportion of patients (%) | ||
---|---|---|---|
Primary diseases | Multiple sclerosis | 5 | 88.3 |
Melanoma | 1 | 16.7 | |
Sex | Male | 6 | 33.3 |
Female | 2 | 66.7 | |
Age of sarcoidosis onset (mean ± standard deviation) | Overall: 40.2 ± 11.1 years Men: 48.0 ± 18.4 years Women: 36.3 ± 6.8 years | – | – |
Period until onset | 53.8 months (range, 5–156 months) | – | – |
Organ involvement | Lung* | 6 | 100 |
Lymphadenopathy Hilar | 5 | 83.3 | |
Mediastinal | 4 | 66.6 | |
Abdominal | 1 | 16.6 | |
Skin, spleen | Each 2 | Each 33.3 | |
Liver | 1 | 16.6 | |
Therapy | Discontinuation of IFN | 6 | 100 |
Oral steroid | 5 | 83.3 | |
Other medicine | 3 | 50 | |
Outcome | Resolution | 4 | 66.7 |
Improvement | 1 | 16.6 | |
No change | 1 | 16.6 |